Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: To assess feasibility of lung cancer screening, we analysed lung lesion detectability simulating low-dose and convolutional neural network (CNN) denoised [F]-FDG PET/CT reconstructions.

Methods: Retrospectively, we analysed lung lesions on full statistics and decimated [F]-FDG PET/CT. Reduced count PET data were emulated according to various percentage levels of total. Full and reduced statistics datasets were denoised using a CNN algorithm trained to recreate full statistics PET. Two readers assessed a detectability score from 3 to 0 for each lesion. The resulting detectability score and quantitative measurements were compared between full statistics and the different decimation levels (100%, 30%, 5%, 2%, 1%) with and without denoising.

Results: We analysed 141 lung lesions from 49 patients across 588 reconstructions. The dichotomised lung lesion malignancy score was significantly different from 10% decimation without denoising (p < 0.029) and from 5% decimation with denoising (p < 0.001). Compared to full statistics, detectability score distribution differed significantly from 2% decimation without denoising (p < 0.001) and from 5% decimation with denoising (p < 0.001). Detectability scores at same decimation levels with or without denoising differed significantly at 10%, 2%, and 1% decimation (p < 0.019); dichotomised scores did not differ significantly. Denoising significantly increased the proportion of lung lesion scores with a high diagnostic confidence (3 and 0) (p < 0.038).

Conclusion: Lung lesion detectability was preserved down to 30% of injected activity without denoising and to 10% with denoising. These results support the feasibility of reduced-activity [F]-FDG PET/CT as a potential tool for lung lesion detection. Further studies are warranted to compare this approach with low-dose CT in screening settings.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-025-07259-2DOI Listing

Publication Analysis

Top Keywords

lung lesion
24
lesion detectability
16
[f]-fdg pet/ct
16
full statistics
16
decimation denoising
16
denoising p <
16
detectability score
12
p < 0001
12
lung
9
denoised [f]-fdg
8

Similar Publications

Unlabelled: Encephalitis is a potentially life-threatening condition with infectious or autoimmune aetiologies. Autoimmune encephalitis includes paraneoplastic variants associated with specific onconeural antibodies such as anti-Hu, frequently linked to malignancies. Herpes simplex virus type 1 (HSV-1) is the leading infectious cause in adults.

View Article and Find Full Text PDF

Hepatoid adenocarcinoma of the lung (HAL) is a rare and aggressive subtype of pulmonary adenocarcinoma, with cutaneous metastasis being an uncommon clinical manifestation. A 49-year-old male presented with a painful, nodular skin lesion on the upper back. Histopathological examination confirmed it as a cutaneous metastasis of HAL.

View Article and Find Full Text PDF

Background: Pheochromocytoma (PCC) is a rare neuroendocrine tumor, with 10-15% of cases showing malignant behavior defined by metastatic spread, including exceptionally rare central nervous system (CNS) involvement. Brain metastases present unique diagnostic and therapeutic challenges due to their potential to impair neurological function. This study reports a case of malignant PCC (mPCC) with CNS metastases and a systematic review to clarify the clinical patterns, management strategies, and prognostic factors.

View Article and Find Full Text PDF

We present a unique case of a heart-shaped lesion identified on Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) imaging in a patient with metastatic adenocarcinoma of the left lung. The patient, initially diagnosed with a mass in the left upper lobe and a lytic lesion in the L3 vertebra, underwent chemoradiation therapy. Subsequent imaging revealed significant metabolic activity reduction in lung and vertebral lesions.

View Article and Find Full Text PDF

Lung cancer is the leading cause of cancer and cancer-related deaths, and India ranks the fourth highest country. Lung cancer is a highly aggressive malignancy with a tendency for rapid progression, making early detection and prompt treatment essential for improving patient outcomes. Lung cancer can spread locally into surrounding tissue as well as travel through lymphatics to other parts of the body, most often to bone, brain, liver, and adrenal glands.

View Article and Find Full Text PDF